moderate obstructive lung disease with significant response to bronchodilator, a severe obstructive sleep apnoea on polysomnography and a hgb of 212 and hct of 0.69 on CBC. He was immediately referred to a haematologist and underwent phlebotomy. He had immediate relief of symptoms and hgb decreased to 177, hct 55. He was also started on low dose ICS/LABA and Doxofylline and CPAP with PS of 13 and oxygen of 2 L per minute. On follow up, patient feels great, 02 sat of 96% at room air, normal PFT and sleep study showed moderate sleep apnoea. He was advised to continue CPAP and inhaler.
per minute. On follow up, patient feels great, 02 sat of 96% at room air, normal PFT and sleep study showed moderate sleep apnoea. He was advised to continue CPAP and inhaler.
Conclusion: Based on this case and other OSA cases, secondary erythrocytosis appears to be more common in those with not known OSA.
Awake and nocturnal hypoxemia seems to be more associated with this condition that severity of OSA as measured by AHI. Background and Aims: The purpose of this study was to assess CPAP adherence in Changsha (a representative Chinese city) adults with newly diagnosed OSAHS and assess the influential factors for CPAP adherence in this group.
Methods: A prospective longitudinal study was ongoing at the Second Xiangya Hospital and the Third Xiangya Hospital, CSU, Changsha, China. Consecutive 156 newly diagnosed OSAHS patients (138 males and 18 female, 118 severe and 38 moderate patients) were recruited for study participation. Following the diagnostic PSG, participants completed risk screening questionnaires including The Epworth Sleepiness Scale (ESS), The Health Literacy Screening Questionnaire (HLS). The Selfefficacy Measure in Sleep Apnoea (SEMSA), Sleep Apnoea Quality of Life Index (SAQLI). Participants completed a full-night, in-laboratory CPAP titration with PSG. After the CPAP titration, participants completed The Visual Analogue Scale (VAS) questionnaire about treatment. Participants returned to the sleep center for a scheduled research visit after 30 days of home CPAP treatment. The SPSS 13.0 analysis software was used.
Results: Only 55.8% patients (87 patients, including 80 severe and 7 moderate patients, 78 males and 9 female) had good CPAP adherence. There are difference between good and poor adherence patients in age, ESS, AHI, the lowest SaO 2 , VAS, HLS and SEMSA (Table 1) Methods: Studies investigating the OSA in patients with RBD were systematically retrieved by two independent researchers from MEDLINE, EMBASE and Cochrane Library from inception date to January 2018. The main outcomes included sleep efficiency, subjective sleepiness and neurocognitive function. The Subjective sleepiness was evaluated with Epworth Sleepiness Scale (ESS) while neurocognitive function was evaluated by Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). MMSE was converted to MoCA score to facilitate analysis. The effect of OSA was analyzed by random-effects metaanalysis and expressed as mean differences and 95% confidence intervals (95% CI). The heterogeneity was evaluated with I 2 .
Results: The meta-analysis included 5 studies comprising of 373 RBD patients including 284 patients with OSA (RBD-OSA) and 89 without OSA (RBD-NOSA). The mean age was 62.3 y/o, 79.9% were male, and mean body mass index was 26.5 kg/m 2 . The studies were homogeneous for all three outcomes (I 2 from 0 to 26%). The RBD-OSA had similar sleep efficiency (mean -2.31%; 95% CI -8.80 to 4.17; P = 0.26), ESS (mean −2.03, 95% CI −4.47 to 0.40, P = 0.58), and MoCA score (mean 0.15, 95% CI −3.57, 3.87; P = 0.45) with RBD-NOSA.
Conclusion:
The meta-analysis showed concomitant OSA has no impact on sleep efficiency, sleepiness, and neurocognitive function in RBD patients.
